Aspects of cytotoxic drug penetration, with particular reference to anthracyclines D. J. KerrS. B. Kaye Review Pages: 1 - 5
Flavone acetic acid (LM 975, NSC 347512) A novel antitumor agent Peter J. O'DwyerDale ShoemakerBrian Leyland-Jones Original Articles Pages: 6 - 10
Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde P. M. O'ConnorB. W. Fox Original Articles Pages: 11 - 15
The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung Henrik RoedLars L. VindelovHeine Hoi Hansen Original Articles Pages: 16 - 20
Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cells Kevin J. ScanlonArlene R. CashmoreMaria Saketos Original Articles Pages: 21 - 24
The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells Kevin J ScanlonMohammed Kashani-SabetMaria Saketos Original Articles Pages: 25 - 29
Problems of pharmacokinetic studies on alpha-difluoromethylornithine in mice Johan C. RomijnCarl F. VerkoelenTed A. W. Splinter Original Articles Pages: 30 - 34
Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells Ellen FricheTorben SkovsgaardNis I. Nissen Original Articles Pages: 35 - 39
The enterohepatic circulation of methotrexate in vivo: Inhibition by bile salt Donald GriffinHamid M. Said Original Articles Pages: 40 - 41
Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils Henrik Schrøder Original Articles Pages: 42 - 46
Effects of N-trifluoroacetyladriamycin-14-valerate (AD-32) on human bladder tumor cell lines Harvey B. NiellRobert F. HunterMervyn Israel Original Articles Pages: 47 - 52
Toxicity of 5-fluorouracil for aerobic and hypoxic cells in two murine tumours Ian F. Tannock Original Articles Pages: 53 - 56
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity Marshall P. GorenArlene A. ForastiereCharles B. Pratt Original Articles Pages: 57 - 60
Potentiation of the chemotherapeutic action of 5′-deoxy-5-fluorouridine in combination with guanosine and related compounds Masaaki IigoMasanori MiwaKazuo Nitta Original Articles Pages: 61 - 64
UFT for head and neck cancers: its tissue concentrations and effects on lymphocyte subpopulations Masayoshi TachibanaNorio YasudaOsamu Mizukoshi Original Articles Pages: 65 - 68
Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside H. D. PreislerY. M. RustumR. Priore Original Articles Pages: 69 - 74
Disposition of total and free cisplatin on two consecutive treatment cycles in patients with ovarian cancer Charles ErlichmanSteven J. SoldinSheldon Fine Original Articles Pages: 75 - 79
Phase I trial of combination therapy of cancer with N-phosphanacetyl-L-aspartic acid and dipyridamole Maurie MarkmanThomas C. K. ChanStephen B. Howell Original Articles Pages: 80 - 83
Absence of interaction between furosemide and mitomycin C J. VerweijS. Kerpel-FroniusH. M. Pinedo Short Communication Pages: 84 - 86
Peripheral DTIC neurotoxicity: a case report Maurizio AmichettiSilvano PifferMarcella Piazza Letter to the Editors Pages: 87 - 88
